These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Proceedings of the 7th International Conference on Endothelin. Edinburgh, United Kingdom, 16-19 September 2001. Clin Sci (Lond); 2002 Aug; 103 Suppl 48():1S-473S. PubMed ID: 12428601 [No Abstract] [Full Text] [Related]
5. The role of endothelins in cardiac function in health and disease. Karmazyn M EXS; 1996; 76():209-30. PubMed ID: 8805797 [No Abstract] [Full Text] [Related]
6. The endothelin system. A new target for therapeutic intervention. Yanagisawa M Circulation; 1994 Mar; 89(3):1320-2. PubMed ID: 8124823 [No Abstract] [Full Text] [Related]
9. The role of endothelin in hypertension. Rothermund L; Paul M Curr Opin Nephrol Hypertens; 1998 Jul; 7(4):451-6. PubMed ID: 9690046 [TBL] [Abstract][Full Text] [Related]
10. Endothelin receptor antagonists: actions and rationale for their development. Warner TD; Battistini B; Doherty AM; Corder R Biochem Pharmacol; 1994 Aug; 48(4):625-35. PubMed ID: 8080434 [No Abstract] [Full Text] [Related]
11. New perspectives on the endothelin axis in pain. Barr TP; Kam S; Khodorova A; Montmayeur JP; Strichartz GR Pharmacol Res; 2011 Jun; 63(6):532-40. PubMed ID: 21352917 [No Abstract] [Full Text] [Related]
12. Endothelins and pulmonary hypertension, what directions for the near future? Eddahibi S; Adnot S Eur Respir J; 2001 Jul; 18(1):1-4. PubMed ID: 11510778 [No Abstract] [Full Text] [Related]
13. [Agonists and antagonists to endothelin receptors]. Ihara M; Yano M Tanpakushitsu Kakusan Koso; 1993 Aug; 38(11):1827-40. PubMed ID: 8210428 [No Abstract] [Full Text] [Related]
14. [Involvement of endothelin in the pathogenesis of hypertension and hypertensive target-organ damage]. Kanno K; Hirata Y Nihon Rinsho; 2004 Mar; 62 Suppl 3():164-8. PubMed ID: 15171363 [No Abstract] [Full Text] [Related]
15. Endothelin receptor antagonists. Promising new agents in the management of cardiovascular disorders. Goddard J; Webb DJ Drugs R D; 1999 Jul; 2(1):1-12. PubMed ID: 10560541 [TBL] [Abstract][Full Text] [Related]
17. [ENDOTHELINS: ORIGIN, PHYSIOLOGICAL EFFECTS AND A POSSIBLE ROLE IN PATHOLOGY]. Tuberk Biolezni Legkih; 2010; (5):3-13. PubMed ID: 27534034 [No Abstract] [Full Text] [Related]
19. Endothelins inhibit the mineralization of osteoblastic MC3T3-E1 cells through the A-type endothelin receptor. Hiruma Y; Inoue A; Shiohama A; Otsuka E; Hirose S; Yamaguchi A; Hagiwara H Am J Physiol; 1998 Oct; 275(4):R1099-105. PubMed ID: 9756539 [TBL] [Abstract][Full Text] [Related]
20. The Twelfth International Conference on Endothelin (ET-12), Cambridge 2011. Barton M; Davenport AP Life Sci; 2012 Oct; 91(13-14):462-5. PubMed ID: 22842028 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]